SCHEMBL24929574

SCHEMBL24929574

Cc1oncc1-c1cc(N)c(OC2CCCC2)cc1Cl

nearest known ligand 0.36

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CSNK2A1 P68400 2/20 0.36
PDE4A P27815 6/20 0.34
PDE4B Q07343 6/20 0.34
PDE4C Q08493 6/20 0.34
PDE4D Q08499 6/20 0.34
BRD4 O60885 1/20 0.33
TDO2 P48775 2/20 0.33
CHEK1 O14757 1/20 0.32
RPS6KA3 P51812 1/20 0.32
SRPK1 Q96SB4 1/20 0.32
PDGFRB P09619 1/20 0.31
PDGFRA P16234 1/20 0.31
LMNA P02545 1/20 0.30
MAPT P10636 1/20 0.30
KMT2A Q03164 1/20 0.30
L3MBTL1 Q9Y468 1/20 0.30
ADRA1A P35348 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24928858 0.98 CSNK2A1 (0.33) CSNK2A1PDE4APDE4BPDE4CPDE4D
SCHEMBL24929568 0.85 BRD4 (0.33) BRD4TDO2PDGFRBPDGFRAADRA1A
SCHEMBL24928675 0.85 BRD4 (0.31) BRD4
SCHEMBL24930072 0.79 BRD4 (0.46) PDE4APDE4BPDE4CPDE4DBRD4
SCHEMBL23850721 0.70 ALDH1A1 (0.40) LMNAMAPTKMT2AL3MBTL1
SCHEMBL24930069 0.69 CSNK2A1 (0.39) CSNK2A1PDE4APDE4BPDE4CPDE4D
SCHEMBL31198500 0.69 ACLY (0.38) PDE4APDE4BPDE4CPDE4DBRD4
SCHEMBL27675181 0.67 GAA (0.62) CSNK2A1PDE4APDE4BPDE4CPDE4D
SCHEMBL22636625 0.67 ALDH1A1 (0.36) TDO2LMNAMAPTKMT2AL3MBTL1
SCHEMBL24928863 0.67 CSNK2A1 (0.36) CSNK2A1CHEK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117881657-A Phenyl-sulfamoyl-benzoic acid derivatives as ERAP1 modulators 格雷沃尔夫治疗有限公司 2024-04-12 CN disclosed
WO-2023007188-A1 PHENYL-SULFAMOYL-BENZOIC ACID DERIVATIVES AS ERAP1- MODULATORS Grey Wolf Therapeutics Limited (GB) 2023-02-02 WO disclosed